...
首页> 外文期刊>Journal of Medicinal Chemistry >Potent 7-Hydroxy-l,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid-Based Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease
【24h】

Potent 7-Hydroxy-l,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid-Based Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease

机译:基于强力7-羟基-1,2,3,4-四氢异喹啉-3-羧酸的丙型肝炎病毒NS3蛋白酶大环抑制剂

获取原文
获取原文并翻译 | 示例

摘要

The NS3 protease of hepatitis C virus (HCV) has emerged as one of the best characterized targets for next-generation HCV therapy.The tetrapeptide 1 and pentapeptide 2 are alpha-ketoamide-type HCV serine protease inhibitors with modest potency.We envisioned that the l,2,3,4-tetrahydroisoquinoline-3-carboxylamide (Tic) moiety could be cyclized to the P3 capping group.The resulting macrocycle could enhance the binding through its extra contact with the Ala156 methyl group.Macrocyclization could also provide a less peptidic HCV inhibitor.Synthesis started from dipeptide 5,which was obtained via a coupling of two amino acid derivatives.The N-terminal was capped as hept-6-enoylamide to give 6.Hydroboration of the double bond afforded alcohol 7,the precursor to the macrocycle 8.The macrocyclization was achieved under Mitsunobu conditions (PPh_3,ADDP).The macrocyclic acid 9 was then combined with appropriate right-hand fragments 12,14,or 16,which was prepared from common intermediate 11.Finally,oxidation of alpha-hydroxyamide provided target molecule alpha-ketoamides 17,18,and 21.The C-terminal esters were then elaborated to carboxylic acids 19 and 20,and amides 20 and 23.The inhibitors 17-23 were tested in HCV NS3 protease continuous assay.Tripeptide 17 was more potent than the larger acyclic tetrapeptide 1.The tetrapeptides 18-20 were as active as 17.Most significantly,the pentapeptides (21-23) were much better inhibitors (K_i = 0.015-0.26 mu M).The carboxylic acid (22) and amide (23) were 57-80 times more potent than the acyclic analogue 2.The X-ray crystal structure of compound 23 bound to the protease revealed that the macrocycle adopted a donutlike conformation and had close contact with the Ala 156 methyl group.The ketone carbonyl formed a reversible covalent bond with Ser139.The n-propyl of P1 novaline and the aromatic ring of P2' phenylglycine formed a C-shaped clamp around the Lys136 side chain.
机译:丙型肝炎病毒(HCV)的NS3蛋白酶已成为下一代HCV治疗中最具特征的靶标之一。四肽1和五肽2是α-酮酰胺型HCV丝氨酸蛋白酶抑制剂,具有中等效力。 1,2,3,4-四氢异喹啉-3-羧酰胺(Tic)部分可被环化为P3封端基团,所产生的大环化合物可通过与Ala156甲基的额外接触而增强结合力。 HCV抑制剂。合成是从二肽5开始的,该二肽是通过两个氨基酸衍生物的偶联而获得的.N端被封端为庚6-烯丙基酰胺,得到6.双键加氢生成了7的醇前体。大环酸8在Mitsunobu条件下(PPh_3,ADDP)实现大环化,然后将大环酸9与适当的右侧片段12,14或16结合,后者是由常见的中间体11制备的。 γ,α-羟酰胺的氧化提供目标分子α-酮酰胺17,18和21。然后将C-末端酯精制为羧酸19和20,酰胺20和23。在HCV中测试了抑制剂17-23。 NS3蛋白酶连续测定。三肽17比较大的无环四肽1更有效。四肽18-20的活性与17相同。最显着的是,五肽(21-23)是更好的抑制剂(K_i = 0.015-0.26μM )(22)和酰胺(23)的效力是无环类似物2的57-80倍。与蛋白酶结合的化合物23的X射线晶体结构表明,大环呈甜甜圈状构型并具有紧密的丙炔酮与Ser139形成可逆的共价键,P1 novaline的正丙基和P2'苯基甘氨酸的芳环在Lys136侧链周围形成C形钳位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号